Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes With PrognosisKaren Dybkær, Hans Erik Johnsen, Martin Bøgsted et al.|Journal of Clinical Oncology|2015Cited by 125
High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphomaSara Correia Marques, Karen Dybkær, Benyamin Ranjbar et al.|Experimental Hematology|2016Cited by 68
Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression modelsSteffen Falgreen, Martin Bøgsted, Malene Krag Kjeldsen et al.|BMC Cancer|2015Cited by 65
Generation of a Predictive Melphalan Resistance Index by Drug Screen of B-Cell Cancer Cell LinesMartin Boegsted, Karen Dybkær, Johanne Marie Holst et al.|PLoS ONE|2011Cited by 31
Reproducible probe-level analysis of the Affymetrix Exon 1.0 ST array with R/BioconductorMaría Rodrigo-Domingo, Martin Bøgsted, Rasmus Waagepetersen et al.|Briefings in Bioinformatics|2013Cited by 30